HIV Cured in Ukraine Three Month Results Indicate Promise with Addition of Enercel
The aim of the study was to evaluate Enercel®’s efficacy treating patients with co-infections of tuberculosis and HIV at Regional Antituberculosis Hospital in Chernigov, Ukraine. Specifically, to evaluate improved immune system function (by measuring T-helper or CD4 cells); lessen or eliminate the amount of HIV virus in the bloodstream (HIV viral load); and to verify the elimination of tuberculosis in the lungs (sputum AFB smears and cultures).
View full press release